CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,171 | -63.9% | 180 | -67.7% | 0.00% | -60.0% |
| Q2 2023 | $22,643 | 0.0% | 557 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $22,643 | +0.0% | 557 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $22,642 | -29.2% | 557 | 0.0% | 0.01% | -37.5% |
| Q3 2022 | $32,000 | -56.2% | 557 | -41.9% | 0.01% | -55.6% |
| Q2 2022 | $73,000 | +21.7% | 959 | 0.0% | 0.02% | +28.6% |
| Q1 2022 | $60,000 | -97.2% | 959 | -96.6% | 0.01% | -97.2% |
| Q4 2021 | $2,118,000 | -26.6% | 27,943 | +8.4% | 0.51% | -33.5% |
| Q3 2021 | $2,886,000 | -31.4% | 25,782 | -0.8% | 0.76% | -31.1% |
| Q2 2021 | $4,208,000 | +39.1% | 25,992 | +4.7% | 1.10% | +26.5% |
| Q1 2021 | $3,026,000 | -21.7% | 24,833 | -1.6% | 0.87% | -28.9% |
| Q4 2020 | $3,863,000 | +89.1% | 25,229 | +3.3% | 1.23% | +207.5% |
| Q3 2020 | $2,043,000 | -4.6% | 24,428 | -16.2% | 0.40% | -50.7% |
| Q2 2020 | $2,141,000 | +4360.4% | 29,149 | +2468.2% | 0.81% | +3421.7% |
| Q1 2020 | $48,000 | -36.0% | 1,135 | -8.1% | 0.02% | -23.3% |
| Q4 2019 | $75,000 | +47.1% | 1,235 | 0.0% | 0.03% | +76.5% |
| Q3 2019 | $51,000 | – | 1,235 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |